{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T14:07:38Z","timestamp":1779026858970,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,17]]},"DOI":"10.7759\/cureus.109027","type":"journal-article","created":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T13:51:29Z","timestamp":1779025889000},"source":"Crossref","is-referenced-by-count":0,"title":["Incidental Detection of Diffuse Large B-cell Lymphoma by Non-invasive Prenatal Testing: A Case Report"],"prefix":"10.7759","author":[{"given":"Martin","family":"Vanderdonck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Chiarappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armelle","family":"Duquenne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"De Leener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Van Den Neste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucienne","family":"Michaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-St\u00e9phane","family":"Gatot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lokmane","family":"Taihi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Gheysens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-021-01101-4","article-title":"Outcome of publicly funded nationwide first-tier noninvasive prenatal screening","volume":"23","author":"Van Den Bogaert K","year":"2021","unstructured":"Van Den Bogaert K, Lannoo L, Brison N, et al.. Outcome of publicly funded nationwide first-tier noninvasive prenatal screening. Genet Med. 2021, 23:1137-42. 10.1038\/s41436-021-01101-4","journal-title":"Genet Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/pd.6031","article-title":"Non-invasive prenatal testing suggesting a maternal malignancy: what do we tell the prospective parents in Belgium?","volume":"41","author":"Lannoo L","year":"2021","unstructured":"Lannoo L, Lenaerts L, Van Den Bogaert K, et al.. Non-invasive prenatal testing suggesting a maternal malignancy: what do we tell the prospective parents in Belgium?. Prenat Diagn. 2021, 41:1264-72. 10.1002\/pd.6031","journal-title":"Prenat Diagn"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.1883","article-title":"Presymptomatic identification of cancers in pregnant women during noninvasive prenatal testing","volume":"1","author":"Amant F","year":"2015","unstructured":"Amant F, Verheecke M, Wlodarska I, et al.. Presymptomatic identification of cancers in pregnant women during noninvasive prenatal testing. JAMA Oncol. 2015, 1:814-9. 10.1001\/jamaoncol.2015.1883","journal-title":"JAMA Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/pd.5168","article-title":"An incidental finding of maternal multiple myeloma by non invasive prenatal testing","volume":"37","author":"Imbert-Bouteille M","year":"2017","unstructured":"Imbert-Bouteille M, Chiesa J, Gaillard JB, et al.. An incidental finding of maternal multiple myeloma by non invasive prenatal testing. Prenat Diagn. 2017, 37:1257-60. 10.1002\/pd.5168","journal-title":"Prenat Diagn"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/pd.4857","article-title":"Detection of a case of chronic myeloid leukaemia with deletions at the t(9;22) translocation breakpoints by a genome-wide non-invasive prenatal test","volume":"36","author":"Janssens K","year":"2016","unstructured":"Janssens K, Deiteren K, Verlinden A, et al.. Detection of a case of chronic myeloid leukaemia with deletions at the t(9;22) translocation breakpoints by a genome-wide non-invasive prenatal test. Prenat Diagn. 2016, 36:760-5. 10.1002\/pd.4857","journal-title":"Prenat Diagn"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02260","article-title":"Noninvasive prenatal test results indicative of maternal malignancies: a nationwide genetic and clinical follow-up study","volume":"40","author":"Heesterbeek CJ","year":"2022","unstructured":"Heesterbeek CJ, Aukema SM, Galjaard RH, et al.. Noninvasive prenatal test results indicative of maternal malignancies: a nationwide genetic and clinical follow-up study. J Clin Oncol. 2022, 40:2426-35. 10.1200\/JCO.21.02260","journal-title":"J Clin Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/pd.4973","article-title":"Prenatal cfDNA screening results indicative of maternal neoplasm: survey of current practice and management needs","volume":"37","author":"Giles ME","year":"2017","unstructured":"Giles ME, Murphy L, Krsti\u0107 N, Sullivan C, Hashmi SS, Stevens B. Prenatal cfDNA screening results indicative of maternal neoplasm: survey of current practice and management needs. Prenat Diagn. 2017, 37:126-32. 10.1002\/pd.4973","journal-title":"Prenat Diagn"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.07.029","article-title":"Non-invasive, serum DNA pregnancy testing leading to incidental discovery of cancer: a good thing?","volume":"51","author":"Prasad V","year":"2015","unstructured":"Prasad V. Non-invasive, serum DNA pregnancy testing leading to incidental discovery of cancer: a good thing?. Eur J Cancer. 2015, 51:2272-4. 10.1016\/j.ejca.2015.07.029","journal-title":"Eur J Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2016.109","article-title":"Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies","volume":"19","author":"Mackley MP","year":"2017","unstructured":"Mackley MP, Fletcher B, Parker M, Watkins H, Ormondroyd E. Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies. Genet Med. 2017, 19:283-93. 10.1038\/gim.2016.109","journal-title":"Genet Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2016.190","article-title":"Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics","volume":"19","author":"Kalia SS","year":"2017","unstructured":"Kalia SS, Adelman K, Bale SJ, et al.. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Genet Med. 2017, 19:249-55. 10.1038\/gim.2016.190","journal-title":"Genet Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-021-01171-4","article-title":"Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG)","volume":"23","author":"Miller DT","year":"2021","unstructured":"Miller DT, Lee K, Gordon AS, et al.. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021, 23:1391-8. 10.1038\/s41436-021-01171-4","journal-title":"Genet Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1200\/PO.20.00429","article-title":"Cancer diagnoses following abnormal noninvasive prenatal testing: a case series, literature review, and proposed management model","volume":"5","author":"Dow E","year":"2021","unstructured":"Dow E, Freimund A, Smith K, et al.. Cancer diagnoses following abnormal noninvasive prenatal testing: a case series, literature review, and proposed management model. JCO Precis Oncol. 2021, 5:1001-12. 10.1200\/PO.20.00429","journal-title":"JCO Precis Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.802865","article-title":"Effective identification of maternal malignancies in pregnancies undergoing noninvasive prenatal testing","volume":"13","author":"Li J","year":"2022","unstructured":"Li J, Ju J, Zhao Q, et al.. Effective identification of maternal malignancies in pregnancies undergoing noninvasive prenatal testing. Front Genet. 2022, 13:802865. 10.3389\/fgene.2022.802865","journal-title":"Front Genet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1515\/medgen-2023-2055","article-title":"Non-invasive prenatal testing: when results suggests maternal cancer","volume":"35","author":"Lenaerts L","year":"2023","unstructured":"Lenaerts L, Theunis M, Amant F, Vermeesch JR. Non-invasive prenatal testing: when results suggests maternal cancer. Med Genet. 2023, 35:285-95. 10.1515\/medgen-2023-2055","journal-title":"Med Genet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-09-297879","article-title":"Double-hit B-cell lymphomas","volume":"117","author":"Aukema SM","year":"2011","unstructured":"Aukema SM, Siebert R, Schuuring E, van Imhoff GW, Kluin-Nelemans HC, Boerma EJ, Kluin PM. Double-hit B-cell lymphomas. Blood. 2011, 117:2319-31. 10.1182\/blood-2010-09-297879","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-04-1399","article-title":"Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction","volume":"106","author":"Bea S","year":"2005","unstructured":"Bea S, Zettl A, Wright G, et al.. Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction. Blood. 2005, 106:3183-90. 10.1182\/blood-2005-04-1399","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz R","year":"2018","unstructured":"Schmitz R, Wright GW, Huang DW, et al.. Genetics and pathogenesis of diffuse large B-cell lymphoma. N Engl J Med. 2018, 378:1396-407. 10.1056\/NEJMoa1801445","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-03-276766","article-title":"Immunoblastic morphology but not the immunohistochemical GCB\/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL","volume":"116","author":"Ott G","year":"2010","unstructured":"Ott G, Ziepert M, Klapper W, et al.. Immunoblastic morphology but not the immunohistochemical GCB\/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL. Blood. 2010, 116:4916-25. 10.1182\/blood-2010-03-276766","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2017.282459","article-title":"Unusual prenatal genomic results provide proof-of-principle of the liquid biopsy for cancer screening","volume":"64","author":"Bianchi DW","year":"2018","unstructured":"Bianchi DW. Unusual prenatal genomic results provide proof-of-principle of the liquid biopsy for cancer screening. Clin Chem. 2018, 64:254-6. 10.1373\/clinchem.2017.282459","journal-title":"Clin Chem"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/hvae170","article-title":"Incidental detection of maternal cancer following cell-free DNA screening for fetal aneuploidies","volume":"71","author":"Goldlust IS","year":"2025","unstructured":"Goldlust IS, Bianchi DW. Incidental detection of maternal cancer following cell-free DNA screening for fetal aneuploidies. Clin Chem. 2025, 71:61-8. 10.1093\/clinchem\/hvae170","journal-title":"Clin Chem"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/483531-incidental-detection-of-diffuse-large-b-cell-lymphoma-by-non-invasive-prenatal-testing-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T13:51:30Z","timestamp":1779025890000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/483531-incidental-detection-of-diffuse-large-b-cell-lymphoma-by-non-invasive-prenatal-testing-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,17]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.109027","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,17]]}}}